Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

FDA Approves Neoadjuvant Opdivo and Chemotherapy for Resectable Non-Small Cell Lung Cancer Treatment Pathway

Read more

Recordati Strengthens Rare Diseases Portfolio with Acquisition of Global Rights to Enjaymo

Read more

Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment

Read more

Charles River and Lundbeck Collaborate to Harness AI-Powered Logica for Novel Neurological Drug Discovery

Read more

Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma

Read more

South Korea’s SK bioscience Completes Acquisition of Germany’s CDMO IDT Biologika

Read more

ABL Bio Launches Clinical Collaboration to Assess ABL103 with KEYTRUDA in Solid Tumor Patients

Read more

Gilead Partners with Six Generic Manufacturers for Royalty-Free Licensing to Boost Lenacapavir Access for HIV Prevention in Resource-Limited Countries

Read more

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus

Read more

GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies

Read more

Posts pagination

Previous Page 1 of 923 … Page 101 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version